Chromogranin A: any relevance in neuroendocrine tumors?


PURPOSE OF REVIEW The review summarizes the utility and limitations of chromogranin A (CgA) as a circulating biomarker for neuroendocrine tumors (NETs). RECENT FINDINGS Blood CgA measurement has numerous clinical limitations including poor assay reproducibility, low sensitivity (meta-analysis: 73%, 95% confidence interval: 0.71-0.76), and a paucity of… (More)
DOI: 10.1097/MED.0000000000000215


5 Figures and Tables